Blog | SYNERGY HomeCare

Alzheimer's Research

Solanezumab, a once-promising Alzheimer’s drug, hit a snag when tests showed it didn’t slow the progression of the disease as much as originally thought. However, researchers looked at combined results of a pair of different studies and found that in patients with mild forms of the disease, it may work better than earlier research indicated, The New York Times reports. 

Read More